Detailed information for compound 271658

Basic information

Technical information
  • TDR Targets ID: 271658
  • Name: 1-benzyl-1-hydroxy-3-[3-methoxy-2-propoxy-5-[ 5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl] urea
  • MW: 566.642 | Formula: C31H38N2O8
  • H donors: 2 H acceptors: 2 LogP: 4.57 Rotable bonds: 14
    Rule of 5 violations (Lipinski): 2
  • SMILES: CCCOc1c(cc(cc1OC)C1CCC(O1)c1cc(OC)c(c(c1)OC)OC)NC(=O)N(Cc1ccccc1)O
  • InChi: 1S/C31H38N2O8/c1-6-14-40-29-23(32-31(34)33(35)19-20-10-8-7-9-11-20)15-21(16-26(29)36-2)24-12-13-25(41-24)22-17-27(37-3)30(39-5)28(18-22)38-4/h7-11,15-18,24-25,35H,6,12-14,19H2,1-5H3,(H,32,34)
  • InChiKey: GODQIDMDYBTWQN-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-benzyl-1-hydroxy-3-[3-methoxy-2-propoxy-5-[5-(3,4,5-trimethoxyphenyl)tetrahydrofuran-2-yl]phenyl]urea
  • 1-benzyl-1-hydroxy-3-[3-methoxy-2-propoxy-5-[5-(3,4,5-trimethoxyphenyl)-2-tetrahydrofuranyl]phenyl]urea
  • 1-hydroxy-3-[3-methoxy-2-propoxy-5-[5-(3,4,5-trimethoxyphenyl)oxolan-2-yl]phenyl]-1-(phenylmethyl)urea
  • 1-hydroxy-3-[3-methoxy-2-propoxy-5-[5-(3,4,5-trimethoxyphenyl)tetrahydrofuran-2-yl]phenyl]-1-(phenylmethyl)urea
  • 1-hydroxy-3-[3-methoxy-2-propoxy-5-[5-(3,4,5-trimethoxyphenyl)-2-tetrahydrofuranyl]phenyl]-1-(phenylmethyl)urea
  • 1-(benzyl)-1-hydroxy-3-[3-methoxy-2-propoxy-5-[5-(3,4,5-trimethoxyphenyl)tetrahydrofuran-2-yl]phenyl]urea

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens platelet-activating factor receptor Starlite/ChEMBL No references
Rattus norvegicus Arachidonate 5-lipoxygenase Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus granulosus arachidonate 5 lipoxygenase Get druggable targets OG5_127482 All targets in OG5_127482
Echinococcus multilocularis arachidonate 5 lipoxygenase Get druggable targets OG5_127482 All targets in OG5_127482
Schistosoma mansoni lipoxygenase Get druggable targets OG5_127482 All targets in OG5_127482
Schistosoma japonicum IPR001024,Lipoxygenase, LH2;IPR013819,Lipoxygenase, C-terminal,domain-containing Get druggable targets OG5_127482 All targets in OG5_127482
Schistosoma mansoni lipoxygenase Get druggable targets OG5_127482 All targets in OG5_127482
Schistosoma japonicum ko:K00461 arachidonate 5-lipoxygenase [EC1.13.11.34], putative Get druggable targets OG5_127482 All targets in OG5_127482

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus granulosus g-protein coupled receptor platelet-activating factor receptor 342 aa 302 aa 22.2 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Giardia lamblia Aldose reductase 0.011 0.4948 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.011 0.4948 0.4948
Echinococcus multilocularis aldo keto reductase 0.011 0.4948 0.4948
Trichomonas vaginalis aldo-keto reductase, putative 0.011 0.4948 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.011 0.4948 0.4948
Onchocerca volvulus 0.011 0.4948 0.5
Onchocerca volvulus 0.011 0.4948 0.5
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.011 0.4948 0.5
Leishmania major aldehyde reductase, putative,oxidoreductase, putative 0.011 0.4948 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.011 0.4948 0.5
Mycobacterium ulcerans oxidoreductase 0.011 0.4948 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.011 0.4948 0.4948
Trypanosoma brucei prostaglandin f synthase 0.011 0.4948 0.5
Leishmania major aldo-keto reductase-like protein 0.011 0.4948 0.5
Loa Loa (eye worm) oxidoreductase 0.011 0.4948 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.011 0.4948 0.4948
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.011 0.4948 0.4948
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.011 0.4948 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.011 0.4948 0.4948
Onchocerca volvulus 0.011 0.4948 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.011 0.4948 0.4948
Trichomonas vaginalis aldo-keto reductase, putative 0.011 0.4948 0.5
Trichomonas vaginalis aldo/keto reductase, putative 0.011 0.4948 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.011 0.4948 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.011 0.4948 0.4948
Schistosoma mansoni pol-related 0.011 0.4948 0.2415
Mycobacterium tuberculosis Probable oxidoreductase 0.011 0.4948 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.011 0.4948 0.5
Entamoeba histolytica aldose reductase, putative 0.011 0.4948 0.5
Trypanosoma cruzi aldo/keto reductase, putative 0.011 0.4948 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.011 0.4948 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.011 0.4948 0.4948
Echinococcus granulosus aldo keto reductase family 1 member B4 0.011 0.4948 0.4948
Trichomonas vaginalis dihydrodiol dehydrogenase, putative 0.011 0.4948 0.5
Onchocerca volvulus 0.011 0.4948 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.011 0.4948 0.4948
Loa Loa (eye worm) oxidoreductase 0.011 0.4948 0.5
Trichomonas vaginalis aldo/keto reductase, putative 0.011 0.4948 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.011 0.4948 0.4948
Onchocerca volvulus 0.011 0.4948 0.5
Loa Loa (eye worm) oxidoreductase 0.011 0.4948 0.5
Echinococcus multilocularis aldo keto reductase 0.011 0.4948 0.4948
Onchocerca volvulus 0.011 0.4948 0.5
Trypanosoma brucei aldo-keto reductase, putative 0.011 0.4948 0.5
Echinococcus granulosus aldo keto reductase 0.011 0.4948 0.4948
Leishmania major prostaglandin f synthase, putative 0.011 0.4948 0.5
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.011 0.4948 0.5
Trypanosoma cruzi aldo-keto reductase 0.011 0.4948 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.011 0.4948 0.5
Trichomonas vaginalis aldo/keto reductase, putative 0.011 0.4948 0.5
Mycobacterium leprae PROBABLE OXIDOREDUCTASE 0.011 0.4948 1
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.011 0.4948 0.4948
Giardia lamblia Aldose reductase 0.011 0.4948 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.011 0.4948 0.4948
Trichomonas vaginalis aldo-keto reductase, putative 0.011 0.4948 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.011 0.4948 0.4948
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.011 0.4948 0.4948
Trichomonas vaginalis aldo-keto reductase, putative 0.011 0.4948 0.5
Echinococcus granulosus aldo keto reductase 0.011 0.4948 0.4948
Loa Loa (eye worm) oxidoreductase 0.011 0.4948 0.5
Trichomonas vaginalis dihydrodiol dehydrogenase, putative 0.011 0.4948 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.011 0.4948 0.5
Leishmania major prostaglandin f2-alpha synthase/D-arabinose dehydrogenase 0.011 0.4948 0.5
Echinococcus granulosus hypothetical protein 0.011 0.4948 0.4948
Echinococcus multilocularis arachidonate 5 lipoxygenase 0.0142 1 1
Entamoeba histolytica aldose reductase, putative 0.011 0.4948 0.5
Echinococcus granulosus aldo keto reductase family 1 member B4 0.011 0.4948 0.4948
Schistosoma mansoni aldo-keto reductase 0.011 0.4948 0.2415
Trichomonas vaginalis aldo-keto reductase, putative 0.011 0.4948 0.5
Trichomonas vaginalis aldo-keto reductase, putative 0.011 0.4948 0.5
Echinococcus multilocularis aldo keto reductase 0.011 0.4948 0.4948
Brugia malayi oxidoreductase, aldo/keto reductase family protein 0.011 0.4948 0.5
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.011 0.4948 0.4948
Echinococcus granulosus aldo keto reductase family 1 member B4 0.011 0.4948 0.4948
Echinococcus multilocularis aldo keto reductase family 1, member B4 0.011 0.4948 0.4948
Schistosoma mansoni lipoxygenase 0.0142 1 1
Echinococcus granulosus aldo keto reductase 0.011 0.4948 0.4948
Loa Loa (eye worm) hypothetical protein 0.011 0.4948 0.5
Schistosoma mansoni aldo-keto reductase 0.011 0.4948 0.2415
Toxoplasma gondii aldose reductase, putative 0.011 0.4948 0.5
Entamoeba histolytica aldose reductase, putative 0.011 0.4948 0.5
Trichomonas vaginalis dihydrodiol dehydrogenase, putative 0.011 0.4948 0.5
Loa Loa (eye worm) oxidoreductase 0.011 0.4948 0.5
Echinococcus multilocularis aldo keto reductase 0.011 0.4948 0.4948

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 423 nM In vitro affinity for human PAF receptor on platelet membranes using [3H]-PAF displacement. ChEMBL. No reference
IC50 (binding) = 423 nM In vitro affinity for human PAF receptor on platelet membranes using [3H]-PAF displacement. ChEMBL. No reference
IC50 (binding) = 585 nM In vitro affinity for human PAF receptor on platelet membranes using [3H]-PAF displacement. ChEMBL. No reference
IC50 (binding) = 585 nM In vitro affinity for human PAF receptor on platelet membranes using [3H]-PAF displacement. ChEMBL. No reference
IC50 (functional) = 2.24 uM In vitro inhibition of 5-lipoxygenase in RBL-2H3 (Rat basophilic leukaemia) cells. ChEMBL. No reference
IC50 (functional) = 2.24 uM In vitro inhibition of 5-lipoxygenase in RBL-2H3 (Rat basophilic leukaemia) cells. ChEMBL. No reference
IC50 (functional) = 8 uM In vitro inhibition of 5-lipoxygenase in RBL-2H3 (Rat basophilic leukaemia) cells. ChEMBL. No reference
IC50 (functional) = 8 uM In vitro inhibition of 5-lipoxygenase in RBL-2H3 (Rat basophilic leukaemia) cells. ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.